Distinguished in Scleroderma

Emmanuel Chatelus

Strasbourg, FR 
Distinguished in Scleroderma
Strasbourg, FR 
OverviewLocationsClinical Research

Overview

Emmanuel Chatelus practices in Strasbourg, France. Mr. Chatelus is rated as a Distinguished expert by MediFind in the treatment of Scleroderma. His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Arthritis, and Rheumatoid Arthritis (RA).

His clinical research consists of co-authoring 67 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 28 articles and participated in 2 clinical trials in the study of Scleroderma.

Gender
Male

Locations

Strasbourg, France
Other Locations
France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Optical Coherence Tomography Imaging in Systemic Sclerosis
Optical Coherence Tomography Imaging in Systemic Sclerosis
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Randomized Controlled Trial Comparing Botulin Toxin Versus Hyaluronic Acid by Intra-articular Injection for the Treatment of Painful Knee Osteoarthritis
Randomized Controlled Trial Comparing Botulin Toxin Versus Hyaluronic Acid by Intra-articular Injection for the Treatment of Painful Knee Osteoarthritis
Enrollment Status: Unknown
Publish Date: September 14, 2021
Intervention Type: Device, Drug
Study Drugs: Botulinum Toxin A, Hyaluronic Acid
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Multicentre Proof-of-concept Trial of IVA337 in the Treatment of Diffuse Cutaneous Systemic Sclerosis
A Randomized, Double-blind, Placebo-controlled, Multicentre Proof-of-concept Trial of IVA337 in the Treatment of Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Completed
Publish Date: March 04, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

67 Total Publications

Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc).
Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc).
Journal: Journal of autoimmunity
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Chatelus's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile